Rosenblatt raised the firm’s price target on Adtran (ADTN) to $15 from $10 and keeps a Buy rating on the shares. The firm sees an “elevated probability” that Adtran can report better than modeled forecasts and grow into its valuation.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADTN: